Bcl-6

BT-AP06303

Rabbit

IgG

100ul,50ul,20ul

Polyclonal

Synthesized peptide derived from human Bcl-6 (Acetyl Lys379)

The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.

1 mg/ml

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

-20°C for 1 year

disease:A chromosomal aberration involving BCL6 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with POU2AF1/OBF1.|disease:A chromosomal aberration involving BCL6 may be a cause of lymphoma. Translocation t(3;4)(q27;p11) with ARHH/TTF.|disease:Chromosomal aberrations involving BCL6 may be a cause of B-cell non-Hodgkin lymphoma. Translocation t(3;14)(q27;q32); translocation t(3;22)(q27;q11) with immunoglobulin gene regions.|Transcriptional repressor which is required for germinal center formation and antibody affinity maturation. Probably plays an important role in lymphomagenesis.|induction:Down-regulated during maturation of dendritic cells by selective stimuli such as LPS| CD40L and zymosan.|PTM:Phosphorylated by MAPK1 in response to antigen receptor activation. Phosphorylation induces its degradation by ubiquitin/proteasome pathway.|Contains 1 BTB (POZ) domain.|Contains 6 C2H2-type zinc fingers.|subunit:Interacts with ZBTB7 and BCL6B (By similarity). Interacts with the catalytic domain of HDAC9.|tissue specificity:Expressed in germinal center T and B cells and in primary immature dendritic cells.|

Human:;Mouse:;

77660

Human: 604; Mouse: 12053

Bcl-6 ;Acetyl Lys379; B-cell lymphoma 6 protein; BCL-6; B-cell lymphoma 5 protein; BCL-5; Protein LAZ-3; Zinc finger and BTB domain-containing protein 27; Zinc finger protein 51

Cancer; Epigenetics and nuclear signaling; Cell biology

BCL6